Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Structure-based drug design identifies novel LPA3 antagonists
HTML
Details
Locations
Year:
2009
Type:
article
Source:
Bioorganic & Medicinal Chemistry
DOI:
10.1016/j.bmc.2009.09.022
Authors:
James I. Fells,
Ryoko Tsukahara,
Jianxiong Liu,
Gabor Tigyi,
Abby L. Parrill
Institutions:
University of Memphis,
University of Tennessee Health Science Center
Language:
English
Topic:
Sphingolipid Metabolism and Signaling
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
LPA3 receptor,
lysophosphatidic acid,
receptor antagonists,
structure-based drug design,
virtual screening,
similarity search,
pharmacophore,
isoindole derivatives,
compound 5
show all 9
SDG:
Good health and well-being
Open Access status:
green
Funders:
American Heart Association,
Ministry of Earth Sciences,
Ministry of Education, India,
National Institutes of Health,
National Heart, Lung, and Blood Institute,
National Cancer Institute
show all 6
Awards:
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis,
Computational Approach to Ligand Discovery for LPA GPCR and PPAR
OpenAlex ID:
W2095200469
FWCI:
0.782
Cites:
24
Cited by:
34
Related to:
10